ScholarIQanswers from OpenAlex
Phosphodiesterase function and regulation
TopicLeading institutions, researchers & key papers
Phosphodiesterase function and regulation is a topic indexed in ScholarIQ from OpenAlex.
What is known about Phosphodiesterase function and regulation?
ScholarIQrecord summary
This cluster of papers focuses on the molecular regulation and clinical applications of cyclic nucleotide phosphodiesterases (PDEs), particularly in the context of cAMP signaling, schizophrenia genetics, neuronal development, therapeutic targeting, compartmentalized signaling, Alzheimer's disease treatment, cardiac function regulation, and the development of phosphodiesterase inhibitors.
How many works does Phosphodiesterase function and regulation have?
ScholarIQindexed works
Phosphodiesterase function and regulation has 69 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Phosphodiesterase function and regulation?
ScholarIQopenalex
The OpenAlex for Phosphodiesterase function and regulation is on the source record.
What are the most-cited papers on Phosphodiesterase function and regulation?
ScholarIQmost cited works
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini, Kristen F. Meckel, Michael J. Kelso, Kimberly Noonan, Joseph A. Califano, Wayne M. Koch, Luigi Dolcetti, Vincenzo Bronte, Ivan Borrello
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Heng Li, Jianping Zuo, Wei Tang
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
C. Paul, Jennifer Clay Cather, Melinda Gooderham, Yves Poulin, Ulrich Mrowietz, C. Ferrandiz, J. Crowley, ChiaChi Hu, R.M. Stevens, Kara N. Shah, R. M. Day, Giampiero Girolomoni, A.B. Gottlieb
Association of DISC1/TRAX Haplotypes With Schizophrenia, Reduced Prefrontal Gray Matter, and Impaired Short- and Long-term Memory
Tyrone D. Cannon, William Hennah, Theo G.M. van Erp, Paul M. Thompson, Jouko Lönnqvist, Matti Huttunen, Timothy L. Gasperoni, Annamari Tuulio‐Henriksson, Tia Pirkola, Arthur W. Toga, Jaakko Kaprio, John C. Mazziotta, Leena Peltonen
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley, C. Birbara, Janusz Jaworski, Jacob Aelion, Randall M. Stevens, Adele R. Vessey, Xiaojiang Zhan, Paul Bird
Where is Phosphodiesterase function and regulation research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Phosphodiesterase function and regulation is open access?
ScholarIQopen access share
80%OPEN ACCESS